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Medical Center, Chicago, Illinois. U . S . A. 
Blood and brain levels of gamma benzene hexachloride have been measured following 
topical application in guinea pigs. Levels increased with number of applications, and the 
concentration in brain was at least 10 times greater than in blood. 
Gamma benzene hexachloride (GBH) (y-hexa-
chlorocyclohexane, lindane, Kwell , Gamene), a 
chlorinated hydrocarbon pesticide, is widely used 
in veterinary and human medicine for the treat-
ment of pediculosis and scabies. The toxicology of 
GBH has recently been reviewed [1]. It has been 
extensively studied, and the central nervous sys-
tem toxicity of the agent is well documented in 
humans after intravenous and oral administration 
or by inhalation [2]. 
Feldman and Maibach [3] measured urinary ex-
cretion after intravenous and topical administra-
tion ofGBH in humans. They found that 9.3% of a 
measured quantity applied to normal skin was 
excreted in the urine within 5 days, suggesting 
that at least 9.3% of GBH is absorbed percuta-
neously. There is, however, little substantive evi-
dence in the literature documenting percutaneous 
absorption or CNS toxicity in humans after topical 
application of the commercially available dosage 
forms of GBH. Because of this, we felt it would be 
of interest to examine the quantitative and rela-
tive distribution of GBH in blood and brain tissue 
after topical application of 1% GBH lotion in 
guinea pigs. 
MATERIALS AND METHODS 
Twelve newborn guinea pigs ar.d 20 2-month-old 
guinea pigs were used. They were random bred and 
from multiple litters of either sex. The newborn ani-
mals were born on the same day within the week of the 
experiment and had a mean weight of97 gm (range 73-
120 gm). The 2-month old guinea pigs had a mean 
weight of 302 gm (range 278-356 gml. 
All animals had their hair clipped from the neck t.o 
the hind legs to a length of approximately 1 mm. The 
animals were kept in separate cages and were not 
washed at any time during the experiment. All of the 
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animals had normal skin by inspection throughout the 
experiment. 
Each group of newborn and 2-month old guinea pigs 
was divided into 3 subgroups (A, B, and C). There were 
3 control animals for each age group. GBH (Kwelll 1% 
lotion* was measured in B-D plastic disposable sy-
ringes , and 2 ml (20 mg) was uniformly applied to the 
clipped area of each animal (except controls) with mini-
mal r ubbing. Twenty-four hours after initial applica-
tion single blood samples were taken from Group A 
animals in both age groups by cardiac puncture using 
heparinized B-D plastic disposable syrmges and 22-
gauge needles. The blood volumes taken were approxi-
mately 0.2 ml each. The samples were placed in plastic-
stoppered glass test tubes and frozen at - 2o•c until 
analyzed by gas-liquid chromatography (GLCJ. Imme-
diately after blood samples were taken, the Group A 
animals were sacrificed by injecting 0.5 ml of Euthana-
sia regulart into the peritoneum. Whole brain tissue 
was then removed, placed in rubber-stoppered glass 
test tubes, and immediately frozen at - zo•c for GLC 
analysis . 
At. 24 hr after initial application, GBH was reapplied 
as before to Groups Band C of both age groups. At 48 hr 
after the initial application, the animals in the B 
groups had blood and brain samples taken in a manner 
identical to that of the A groups. Also, at 48 hr. a third 
application of GBH was applied to Group C in both age 
groups. The animals had blood and brain samples taken 
at 72 hr after initial application fsee Tab. JJ. 
For GLC analysis, a modification of the extraction 
procedure of Litterest and Miller [4) was used. Aliquots 
of 400 p.l or less were taken from the blood samples and 
diluted with an equal volume of methyl alcohol:water 
(1:1, v/v). The diluted samples were extracted with 5 
volumes of hexane by vortexing for 30 sec. The tubes 
were centrifuged aL 2000 x g for 5 min, and the extracts 
* Kwelllotion (gamma benzene hexachlor ide lotion, 
U .S.P .) formula: active ingredient lindane (gamma 
benzene hexachloride, U .S.P .l 1%. Inert ingredients 
99'11: , containing glyceryl monostearate, ceytl alcohol, 
stearic acid, triethanolamine, 2-amino-2 methyl-L-pro-
panol, butyl p-hydroxybenzoate, methyl p-hydroxyben-
zoate, irish moss extract, perfume, and purified water. 
Manufactured for Reed and Carnrick, Kenilworth , N.J . 
07033 by Reed Co., Inc. Humacao, P.R. 00661. 
t Euthanasia regular injection, each ml contains so· 
dium pentobarbital 195 mg, propylene glycol 20%, diso-
dium salt of 1,4 BIS (o-sulf-p-tolueno)-anthraquinone 
0.0037 mg, benzoyl alcohol 2%. 
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TABLE I. Summary of gamma benzene hexachloride leuels 
Group Blood (1-'g/ml or ppm) Brain (1-'g/g or ppm! 
Two-month-old guinea pigs 
0, 0, 0 (0.20), 0, 0 
Brain to 
blood ratio 
A 
B 
c 
Control (n = 3) 
24 hr (n = 6) 
48 hr (n = 5) 
72 hr (n = 6) 
0.12'' (0.019-0.31)b::!: 0.1 ' 
0.26 (0.12-0.68) :!: 0.2 
0.57 (0.35-1.10) ± 0.3 
2.6 (0.6-7.4)::!: 2.5 
6.4 (1. 9-21.0) ::!: 8.2 
8.3 (4.7-14.2)::!: 3.5 
22.9d 
20.0 
15.0 
Control (n = 3) 
24 hr ( n = 3) 
48 hr (n = 3) 
72 hr ( n = 3) 
Newborn guinea ptgs 
(0.022), 0, 0 0, 0, 0 
A 
B 
c 
" Mean levels of GBH 
b Range of GBH levels 
' Standard deviation 
0.43 (0.25-0.64) ± 0.2 
0.47 <0.29-0. 70) ± 0.2 
0.81 (0.56-0.99) ~ 0.2 
d Mean ratio of brain to blood levels 
TABLE II. GBH concentration in blood and brain after 
toptcal applicatiOn 
• 
' 
2 MDNiH o.._r 
(1.4-7 .4 IJ.) ) were mjected into the gas chromatograph. 
The whole brain samples were washed twice with 5 
ml of Ringer's solution to remove any excess blood. 
Representative brain tissues, 2.1 gm or less, were then 
homogenized with 2 volumes !w/v of methyl alco-
hol:water, 1:3, v/vl in a ten Broeck glass tissue grinder. 
The homogenate was mixed on a Vortex mixer for 30 sec 
with 4 volumes (w/v) of hexane and centrifuged at 2000 
x g for 5 min. This was repeated twice, and all 3 hexane 
extracts were combined. The extracts were injected 
(2.5-6.4 1-LIJ into the gas chromatograph. 
The amount of hexane extract injected was recorded, 
and the amount of GBH in each sample was calculated 
from the standard curve produced by plotting peak 
heights due to standard GBH in hexane vs amount of 
standard GBH injected. The hexane extracts of blood 
and brain samples were injected with a 10-IJ.l syringe 
into a 2 m by 4 mm (i.d. ) glass column containing a 3% 
CV-17 on Gas Chrom Q 100-120 mesh. The gas chroma-
tograph used was a Packard 7300, equipped with an 
electron capture detector. "3Ni. The GLC conditions 
were: column temperature, 2oo•c ; inlet and detector 
Lemperature, 215•c; and nitrogen flow rate 42 ml!mln 
as measured by bubble flowmeter at the column out-
let). 
RESULTS 
This study documents the percutaneous absorp-
-cion of the commercially available 1% GBH lotion 
n guinea pigs by demonstrating its presence in 
4.5 (4.0-5.10)::!: 0.5 
12.4 (6. 7-10.9) = 6.8 
15.6 (4.6-29.9) = 13.0 
11.9 
28.5 
18.0 
blood and brain tissue of the animals. The results 
are summarized in Tables I and II. Blood and 
brain levels increased with the number of applica-
tions (Tab. D. For all groups the concentration of 
GBH in brain was at least 10 times greater than 
that in blood. Variations in results were not statis-
tically significant between newborn and adult ani-
mals as measured by analysis of variance for une-
qual size groups (Tab. ilL Two control animals or 
samples were inadvertently contaminated and 
contained low levels of G BH detected by the sensi-
tive GLC method. 
DISCUSSION 
Environmental hazards ofGBH and other chlor-
inated hydrocarbon pesticides are the subject of 
much current interest. Each year since 1963 an 
estimated 7 million pounds of GBH have been 
produced in the U.S. The persistence cf GBH in 
the environment ls well documented by studies 
demonstrating continuing presence in river, sew-
age. soil. cow's milk, animal fat, food, and human 
blood samples in various countries despite discon-
tinuance of the use of the agent several years 
earlier in some instances [5-8]. 
The predominant isomer of benzene hexachlor-
ide is the gamma isomer. which has the greatest 
acute toxicity. Acute symptoms are variously de-
scribed as ataxia, weakness, irritability, paraly-
sis, and violent myoclonic convulsions and respira-
tory depression with cyanosis [9]. The systemic 
toxicity of GBH is weU documented by reports of 
ingestion, inhalation, or application in humans 
and animals [10-14]. Human fatalities have oc-
curred by ingestion and are suspected to have 
occurred by combined inhalation and cutaneous 
absorption of highly concentrated forms of GBH 
[15). 
Brain to blood ratio of GBH in dogs after intra-
venous infusion has been determined to be 5 to 12, 
[4), w1th mean blood levels of 0.49 ~-tg/ml. The 
guinea pigs in both age groups in our study 
showed mean brain to blood ratios over a range of 
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12 to 28 after single and multiple topical applica-
tions of 1% GBH lotion, with mean blood levels of 
0.44 JLg/ml. 
We have documented percutaneous absorption 
ofGBH from its commercially available 1% dosage 
form by demonstrating its presence in blood and 
brain tissue of guinea pigs. The significance of this 
fmding regarding humans cannot be commented 
on without speculation. Others have demonstrated 
absorption through the skin in humans [?]. The 
fact that GBH passes through the skin of humans 
in appreciable quantities L2) and that it has an 
affinity for white matter of brain in animals l4] 
should provoke a sense of caution in the practition-
ers prescribing the substance. 
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